Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Standard Biotools (LAB) Gains from Investment Securities (2016 - 2025)

Standard Biotools (LAB) has disclosed Gains from Investment Securities for 14 consecutive years, with -$3.5 million as the latest value for Q4 2025.

  • Quarterly Gains from Investment Securities fell 155.42% to -$3.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$5.4 million through Dec 2025, down 260.08% year-over-year, with the annual reading at $32.5 million for FY2025, 17.0% down from the prior year.
  • Gains from Investment Securities for Q4 2025 was -$3.5 million at Standard Biotools, down from $10.4 million in the prior quarter.
  • The five-year high for Gains from Investment Securities was $10.4 million in Q3 2025, with the low at -$4.3 million in Q3 2022.
  • Average Gains from Investment Securities over 5 years is $1.3 million, with a median of $306000.0 recorded in 2023.
  • The sharpest move saw Gains from Investment Securities tumbled 1131.15% in 2023, then surged 668061.43% in 2025.
  • Over 5 years, Gains from Investment Securities stood at $1.1 million in 2021, then tumbled by 94.52% to $61000.0 in 2022, then crashed by 1131.15% to -$629000.0 in 2023, then tumbled by 120.03% to -$1.4 million in 2024, then plummeted by 155.42% to -$3.5 million in 2025.
  • According to Business Quant data, Gains from Investment Securities over the past three periods came in at -$3.5 million, $10.4 million, and $8.9 million for Q4 2025, Q3 2025, and Q2 2025 respectively.